Lower financials and reporting discrepancies are woes to look out for $SeaStar Medical (ICU.US)$

$Iovance Biotherapeutics (IOVA.US)$
02/20/2024 - 06:30 AM
SAN CARLOS, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (Nasdaq: IOVA) (“Iovance” or “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL”) therapies for patients with cancer, today announced the pricing of an underwritten offering of 23,014,000 shares of its common stock at an offering price of $9.15 per sh...

$SeaStar Medical (ICU.US)$ big attack to trigger all stop losses, careful...

$SeaStar Medical (ICU.US)$ $Tempest Therapeutics (TPST.US)$ Similar flight pattern?